Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Steinert's myotonic dystrophy. Attempts at therapy].

B Fazio1

  • 1Regione Liguria - U.S.L. n. 2 Sanremese - Ospedali Riuniti di Sanremo e Bussana.

Minerva Medica
|February 1, 1988
PubMed
Summary

Myotonic dystrophy, a hereditary disease, presents with various symptoms including muscle issues and heart problems. Current treatments for myotonia are debated, highlighting the need for understanding the disease's biochemical defect for effective therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique.

Nanotechnology·2012
Same author

A mean field analysis of the O-H stretching Raman spectra in methanol/carbon tetrachloride mixtures.

The journal of physical chemistry. B·2006
Same author

Vasculitic neuropathy associated with beta-haemolytic streptococcal infection: a case report.

Italian journal of neurological sciences·1997
Same author

Benign intracranial hypertension associated with HIV infection.

European neurology·1993
Same author

[Diagnostic potentials and limits of nuclear magnetic resonance (NMR) in cerebral neoplastic pathology].

Minerva medica·1989
Same author

[Electric stimulation and neuromuscular diseases. Effects on denervated and dystrophic muscle].

Minerva medica·1988

Area of Science:

  • Genetics and Hereditary Diseases
  • Neuromuscular Disorders
  • Systemic Diseases

Context:

  • Myotonic dystrophy (DM), also known as Steinert's disease, is an autosomal dominant disorder.
  • It affects multiple organ systems, leading to a range of clinical manifestations.
  • Symptoms include myotonia, muscular atrophy, endocrine dysfunction, alopecia, cardiac arrhythmias, hyperglycemia, and cataracts.

Purpose:

  • To review the current understanding of myotonic dystrophy.
  • To discuss the various therapeutic agents that have been investigated for managing myotonia.
  • To emphasize the critical need for identifying the underlying biochemical defect for effective treatment.

Summary:

  • Myotonic dystrophy is a multisystemic autosomal dominant disorder.
  • Numerous drugs, including quinine, corticosteroids, and dantrolene sodium, have been trialed for myotonia with controversial efficacy.
  • Effective treatment necessitates understanding the disease's specific biochemical defect.

Impact:

  • Current therapeutic strategies for myotonic dystrophy symptoms are limited and debated.
  • Further research into the biochemical underpinnings of DM is crucial for developing targeted and effective treatments.
  • This review underscores the importance of molecular insights for advancing patient care in myotonic dystrophy.

Related Experiment Videos